Bisphosphonates and risk of atrial fibrillation: a meta-analysis

INTRODUCTION: Bisphosphonates are the most commonly used drugs for the prevention and treatment of osteoporosis. Although a recent FDA review of the results of clinical trials reported no clear link between bisphosphonates and serious or non-serious atrial fibrillation (AF), some epidemiologic studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seo Young, Kim, Min Jung, Cadarette, Suzanne M, Solomon, Daniel H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875664/
https://www.ncbi.nlm.nih.gov/pubmed/20170505
http://dx.doi.org/10.1186/ar2938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875664/
https://www.ncbi.nlm.nih.gov/pubmed/20170505
http://dx.doi.org/10.1186/ar2938

Ejemplares similares